ALNYLAM PHARMACEUTICALS, INC. - COM (ALNY)

Q2 2024 13F Portfolio Holders as of 6/30/2024

Type / Class
Equity / COM
Number of holders
516
Total Shares
120M
Shares change
+7.52M
Total reported value, excl. options
$29.1B
Value change
+$1.98B
Put/Call ratio
0.92
Number of buys
268
Number of sells
-215
Price
$243.00
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.